Terms: = Ovarian cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
113 results:
1. Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer.
Yuan J; Li X; Wang F; Liu H; Guan W; Xu G
Exp Biol Med (Maywood); 2023 Dec; 248(23):2198-2209. PubMed ID: 38084732
[TBL] [Abstract] [Full Text] [Related]
2. Lysine demethylase 3A in hypoxic macrophages promotes ovarian cancer development through regulation of the vascular endothelial growth factor A/Akt signaling.
Song Y; Li L; Xi Y
Tissue Cell; 2023 Dec; 85():102253. PubMed ID: 37890327
[TBL] [Abstract] [Full Text] [Related]
3. Biological function of C-X-C Motif Chemokine Ligand 1 gene (CXCL1) in ovarian malignant tumors.
Li Z; Huang N; Zhang W; Li L
Hum Exp Toxicol; 2023; 42():9603271231203392. PubMed ID: 37787042
[TBL] [Abstract] [Full Text] [Related]
4. Integrative analysis of cuproptosis-associated genes for predicting immunotherapy response in single-cell and multi-cohort studies.
Li H; Wang Y; Li G; Xiong J; Qin L; Wen Q; Yue C
J Gene Med; 2024 Jan; 26(1):e3600. PubMed ID: 37776237
[TBL] [Abstract] [Full Text] [Related]
5. Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer.
Sheng B; Zhao B; Dong Y; Zhang J; Wu S; Ji H; Zhu X
Carcinogenesis; 2023 Dec; 44(10-11):748-759. PubMed ID: 37747823
[TBL] [Abstract] [Full Text] [Related]
6. REG3A promotes proliferation and DDP resistance of ovarian cancer cells by activating the PI3K/Akt signaling pathway.
Jiang L; Liu Y; Liu M; Zheng Y; Chen L; Shan F; Ji J; Cao Y; Kai H; Kang X
Environ Toxicol; 2024 Jan; 39(1):85-96. PubMed ID: 37665173
[TBL] [Abstract] [Full Text] [Related]
7. cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous ovarian cancer (HGSOC) Based on The cancer Genome Atlas Analysis.
Iżycka N; Zaborowski MP; Ciecierski Ł; Jaz K; Szubert S; Miedziarek C; Rezler M; Piątek-Bajan K; Synakiewicz A; Jankowska A; Figlerowicz M; Sterzyńska K; Nowak-Markwitz E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628927
[TBL] [Abstract] [Full Text] [Related]
8. The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway.
Yang L; Yang M; Cui C; Long X; Li Y; Dai W; Lang T; Zhou Q
Cell Signal; 2023 Jul; 107():110688. PubMed ID: 37105506
[TBL] [Abstract] [Full Text] [Related]
9. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
10. Downregulation of PSAT1 inhibits cell proliferation and migration in uterine corpus endometrial carcinoma.
Wang M; Yue S; Yang Z
Sci Rep; 2023 Mar; 13(1):4081. PubMed ID: 36906716
[TBL] [Abstract] [Full Text] [Related]
11. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer.
Wieser V; Tsibulak I; Reimer DU; Zeimet AG; Fiegl H; Hackl H; Marth C
Gynecol Oncol; 2023 Mar; 170():290-299. PubMed ID: 36758419
[TBL] [Abstract] [Full Text] [Related]
12. FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer.
Zhu W; Huang M; Thakur A; Yan Y; Wu X
PeerJ; 2023; 11():e14827. PubMed ID: 36751636
[TBL] [Abstract] [Full Text] [Related]
13. CircSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression.
Huang C; Qin L; Chen S; Huang Q
Anticancer Drugs; 2023 Mar; 34(3):395-404. PubMed ID: 36729852
[TBL] [Abstract] [Full Text] [Related]
14. Up-regulation of oxidized low-density lipoprotein receptor 1 correlates with decreased miR-106b-5p, miR-93-5p, miR-3129-5p, miR-199b-3p, and miR-4465, higher recurrence rate, and poor prognosis in ovarian cancer.
Liu J; Zeng Y; Zheng L
Histol Histopathol; 2023 Apr; 38(4):475-485. PubMed ID: 36264049
[TBL] [Abstract] [Full Text] [Related]
15. Tumor-Suppressor Gene Transmembrane Protein 98 Promotes Proliferation and Inhibits Apoptosis in ovarian cancer.
Wu SG; Xu JY; Lei J; Hu M; Zhou J
Front Biosci (Landmark Ed); 2022 Jun; 27(7):210. PubMed ID: 35866395
[TBL] [Abstract] [Full Text] [Related]
16. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA LIFR-AS1 overexpression suppressed the progression of serous ovarian carcinoma.
Liu F; Cao L; Zhang Y; Xia X; Ji Y
J Clin Lab Anal; 2022 Aug; 36(8):e25470. PubMed ID: 35778954
[TBL] [Abstract] [Full Text] [Related]
18. Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis.
You J; Han Y; Qiao H; Han Y; Lu X; Lu Y; Wang X; Kai H; Zheng Y
Aging (Albany NY); 2022 Jun; 14(11):4699-4713. PubMed ID: 35687899
[TBL] [Abstract] [Full Text] [Related]
19. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of ovarian Carcinoma Cells.
Yang X; Zhou S; Yang C; Cao C; He M; Zi S
Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of Stathmin 1 Predicts Poor prognosis and Promotes cancer Cell Proliferation and Migration in ovarian cancer.
Nie L; Zhang C; Song H; Zhao Q; Cheng L; Zhang P; Yang X
Dis Markers; 2022; 2022():3554100. PubMed ID: 35186166
[TBL] [Abstract] [Full Text] [Related]
[Next]